ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $179,000 | +15.5% | 43,667 | +0.5% | 0.00% | 0.0% |
Q4 2021 | $155,000 | -2.5% | 43,459 | -0.5% | 0.00% | 0.0% |
Q3 2021 | $159,000 | -15.4% | 43,680 | +1.5% | 0.00% | -50.0% |
Q2 2021 | $188,000 | -0.5% | 43,041 | -6.6% | 0.00% | 0.0% |
Q1 2021 | $189,000 | +3.8% | 46,093 | +0.9% | 0.00% | 0.0% |
Q4 2020 | $182,000 | +42.2% | 45,665 | -3.8% | 0.00% | +100.0% |
Q3 2020 | $128,000 | +33.3% | 47,458 | +35.6% | 0.00% | 0.0% |
Q2 2020 | $96,000 | +11.6% | 34,999 | -3.9% | 0.00% | 0.0% |
Q1 2020 | $86,000 | – | 36,404 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |